A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

Status Completed

Clinical Trial Summary

This is a randomized, placebo controlled and double-blinded study to evaluate the pharmacokinetics (PK), pharmacodynamics (PD) and safety of a single dose (1 mg/kg) of emapalumab in adult healthy Japanese subjects.

Clinical Trial Description

This is a randomized, placebo-controlled and double-blinded study to evaluate the PK, PD and safety of a single dose (1 mg/kg) of emapalumab in adult healthy Japanese subjects, performed in Japan. The subjects, 8 in total, will be randomized to receive either emapalumab or matching placebo in a 3:1 ratio (emapalumab: placebo). ;

Study Design

Related Conditions & MeSH terms

Rare Diseases

Clinical Trial Details

NCT number	NCT04765553
Study type	Interventional
Source	Swedish Orphan Biovitrum
Contact
Status	Completed
Phase	Phase 1
Start date	January 14, 2021
Completion date	July 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05794217` - A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Completed	`NCT03680365` - Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Completed	`NCT03290469` - NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants	N/A
Not yet recruiting	`NCT05955794` - Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes	N/A
Recruiting	`NCT04429750` - Intact Cord Resuscitation in CDH	N/A
Not yet recruiting	`NCT04152876` - Functional Genomics of Rare Genetic Diseases: Realization of Innovative Tools With High Diagnostic Power
Recruiting	`NCT03683966` - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Not yet recruiting	`NCT04319796` - European Registry on Rare Neurological Diseases
Completed	`NCT02736565` - Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma	Phase 1
Completed	`NCT05070988` - Oral Health Related Quality of Life of Patients With Rare Diseases: a Qualitative Approach
Completed	`NCT03563677` - Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases	N/A
Recruiting	`NCT05499091` - Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN	N/A
Completed	`NCT03954652` - Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"	N/A
Recruiting	`NCT05703893` - Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
Enrolling by invitation	`NCT04703179` - Rare and Undiagnosed Disease Research Biorepository
Recruiting	`NCT04024774` - Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases
Recruiting	`NCT06343558` - Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Not yet recruiting	`NCT06412718` - Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Enrolling by invitation	`NCT04654000` - Rheopheresis as Adjuvant Treatment of Calciphylaxis	N/A
Recruiting	`NCT04651439` - Severe Bullous Drug Eruption and Filgrastim	Phase 2/Phase 3